A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic
- PMID: 18398460
- PMCID: PMC2277457
- DOI: 10.1371/journal.pone.0001934
A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic
Abstract
Background: Current recommendations to prevent malaria in African pregnant women rely on insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp). However, there is no information on the safety and efficacy of their combined use.
Methods: 1030 pregnant Mozambican women of all gravidities received a long-lasting ITN during antenatal clinic (ANC) visits and, irrespective of HIV status, were enrolled in a randomised, double blind, placebo-controlled trial, to assess the safety and efficacy of 2-dose sulphadoxine-pyrimethamine (SP). The main outcome was the reduction in low birth weight.
Findings: Two-dose SP was safe and well tolerated, but was not associated with reductions in anaemia prevalence at delivery (RR, 0.92 [95% CI, 0.79-1.08]), low birth weight (RR, 0.99 [95% CI, 0.70-1.39]), or overall placental infection (p = 0.964). However, the SP group showed a 40% reduction (95% CI, 7.40-61.20]; p = 0.020) in the incidence of clinical malaria during pregnancy, and reductions in the prevalence of peripheral parasitaemia (7.10% vs 15.15%) (p<0.001), and of actively infected placentas (7.04% vs 13.60%) (p = 0.002). There was a reduction in severe anaemia at delivery of borderline statistical significance (p = 0.055). These effects were not modified by gravidity or HIV status. Reported ITN's use was more than 90% in both groups.
Conclusions: Two-dose SP was associated with a reduction in some indicators, but these were not translated to significant improvement in other maternal or birth outcomes. The use of ITNs during pregnancy may reduce the need to administer IPTp. ITNs should be part of the ANC package in sub-Saharan Africa.
Trial registration: ClinicalTrials.gov NCT00209781.
Conflict of interest statement
Figures


Similar articles
-
Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Kenya.PLoS One. 2013 Jun 14;8(6):e64913. doi: 10.1371/journal.pone.0064913. Print 2013. PLoS One. 2013. PMID: 23798997 Free PMC article.
-
Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.Am J Trop Med Hyg. 2006 Aug;75(2):205-11. Am J Trop Med Hyg. 2006. PMID: 16896120
-
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial.PLoS One. 2010 Dec 28;5(12):e14425. doi: 10.1371/journal.pone.0014425. PLoS One. 2010. PMID: 21203389 Free PMC article. Clinical Trial.
-
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.Drug Saf. 2007;30(6):481-501. doi: 10.2165/00002018-200730060-00003. Drug Saf. 2007. PMID: 17536875 Review.
-
Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.Lancet Infect Dis. 2013 Dec;13(12):1029-42. doi: 10.1016/S1473-3099(13)70199-3. Epub 2013 Sep 18. Lancet Infect Dis. 2013. PMID: 24054085 Review.
Cited by
-
Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial.Malar J. 2012 May 3;11:150. doi: 10.1186/1475-2875-11-150. Malar J. 2012. PMID: 22554092 Free PMC article. Clinical Trial.
-
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.Clin Infect Dis. 2012 Jul;55(1):42-50. doi: 10.1093/cid/cis301. Epub 2012 Mar 22. Clin Infect Dis. 2012. PMID: 22441649 Free PMC article.
-
Mefloquine for preventing malaria in pregnant women.Cochrane Database Syst Rev. 2018 Nov 14;11(11):CD011444. doi: 10.1002/14651858.CD011444.pub3. Cochrane Database Syst Rev. 2018. PMID: 30480761 Free PMC article.
-
Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery.Infect Immun. 2011 Jan;79(1):298-304. doi: 10.1128/IAI.00814-10. Epub 2010 Nov 1. Infect Immun. 2011. PMID: 21041485 Free PMC article. Clinical Trial.
-
Malaria in pregnancy: the difficulties in measuring birthweight.BJOG. 2011 May;118(6):671-8. doi: 10.1111/j.1471-0528.2010.02880.x. Epub 2011 Feb 18. BJOG. 2011. PMID: 21332632 Free PMC article. Review.
References
-
- World Health Organization (WHO) Brazzaville, Democratic Republic of Congo: WHO Regional Office for Africa,2004; 2006. A strategic framework for malaria prevention and control during pregnancy in the African region: report AFR/MAL/04/01.
-
- Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatibnjie AB. The Effects of Malaria Chemoprophylaxis Given by Traditional Birth Attendants on the Course and Outcome of Pregnancy. Trans R Soc Trop Med Hyg. 1989;83(5):589–94. - PubMed
-
- Brabin B. An Assessment of Low-Birth-Weight Risk in Primiparae As An Indicator of Malaria Control in Pregnancy. Int J Epi. 1991;20(1):276–83. - PubMed
-
- Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 2000;181(5):1740–5. - PubMed
-
- Granja AC, Machungo F, Gomes A, Bergstrom S, Brabin B. Malaria-related maternal mortality in urban Mozambique. Ann Trop Med Parasitol. 1998;92(3):257–63. - PubMed